You have 3 free articles left this month. Get your free Basic subscription now and gain instant access to more.

N. Macedonia's Alkaloid boosts H1 net profit by 11% y/y

N. Macedonia's Alkaloid boosts H1 net profit by 11% y/y Author: Medex / All rights reserved.

SKOPJE (N. Macedonia), July 28 (SeeNews) - North Macedonia-based pharmaceuticals producer Alkaloid [MSE:ALK] said on Thursday that its consolidated net profit grew by an annual 11% in the first half of 2022, reaching 649.4 million denars ($10.7 million/10.5 million euro).

Sales revenue added 14% year-on-year to 7.1 billion denars in the January-June period, Alkaloid said in an interim financial statement filed with the Skopje bourse.

Domestic sales increased by 3%, to 2.3 billion denars, while sales abroad rose 20% to 4.9 billion denars.

The cost of goods sold was 19% higher year-on-year at 4.1 billion denars.

The company’s shares last traded on the Skopje bourse on July 22, at an average price of 16,971 denars, bourse data showed.

Alkaloid has two subsidiaries in North Macedonia and 18 subsidiaries and two representative offices abroad - in Serbia, Montenegro, Kosovo, Albania, Bosnia and Herzegovina, Croatia, Slovenia, Switzerland, Bulgaria, Turkey, Ukraine, Russia, the U.S. and the UK.

The company employs 2,015 people in North Macedonia and 640 in its subsidiaries outside the country.

(1 euro = 61.55 denars)